Unlock instant, AI-driven research and patent intelligence for your innovation.

Histone deacetylase subtype inhibitor sulfur acetyl arylamine compound and use

A technology of acetylase subtype and agent sulfur acetylarylamine, which is applied in the application field of treating tumors or neurodegenerative diseases, can solve the problems of poor pharmacokinetic properties, low bioavailability, strong toxic side effects, etc. Achieve the effects of low normal cell toxicity, strong anti-proliferation activity and low acute toxicity

Active Publication Date: 2022-04-05
SHANGHAI ZHONGZE THERAPEUTICS CO LTD
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005](1) Strong side effects, such as nausea, vomiting, bone marrow suppression, etc.;
[0006](2) genotoxicity;
[0007](3) Poor pharmacokinetic properties, low bioavailability, short half-life, etc.
[0022] The inventors previously discovered a class of compounds containing a sulfhydryl group in the zinc ion binding region (patent application number: 201811052776.2). This type of compound exhibited good inhibitory activity on HDAC6 enzymes, and showed good anti-proliferation activity on tumor cells in vitro, and on nerve cells. Metacells have a protective effect, but the Linker region of this compound is a flexible long carbon chain, and its enzyme subtype selectivity and brain permeability need to be further improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Histone deacetylase subtype inhibitor sulfur acetyl arylamine compound and use
  • Histone deacetylase subtype inhibitor sulfur acetyl arylamine compound and use
  • Histone deacetylase subtype inhibitor sulfur acetyl arylamine compound and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0111] Example 1: Preparation of 2-mercapto-N-(2-(methyl(phenyl)amino)pyrimidin-5-yl)acetamide (1)

[0112]

[0113] Prepared according to the general method of synthesis, the synthetic route is as follows:

[0114]

[0115] Reagents and conditions: (a) HBTU, DIPEA, THF, RT, overnight; (b) TFAA, CH2Cl2, RT, 3h; (c) K2CO3, DMF, 120℃, 6h; (d) H2, Pd / C, RT ,6h.

[0116] Synthesis of N-methyl-5-nitro-N-phenylpyrimidin-2-amine (1-2)

[0117] In a 250ml three-necked flask, add 2-chloro-5-nitropyrimidine (8g, 50.15mmol), potassium carbonate (2eq), N-methylanilinamine (1.1eq) successively, DMF is used as solvent, and under nitrogen protection, 140 ℃ reaction 6h. After cooling to room temperature, the mixture was quenched with ice-water, extracted twice with ethyl acetate, and the organic phase was dried and separated by column chromatography to obtain 8.4 g of a yellow solid with a yield of 72.76%. 1H NMR(600MHz,DMSO-d6)δ:3.58(s,3H),7.31–7.37(m,1H),7.37–7.43(m,2H), 7.47(t,J=...

Embodiment 2

[0124] Example 2 Preparation of 2-mercapto-N-(6-(methyl(phenyl)amino)pyridin-3-yl)acetamide (2)

[0125] 2 was prepared according to the general method.

[0126] 1 H NMR (600MHz, Chloroform-d) δ8.68 (d, J = 1.5Hz, 1H), 7.63 (dd, J = 7.4, 1.5Hz, 1H), 7.37–7.30 (m, 2H), 7.26–7.20 ( m,2H),7.12–7.03(m,2H),3.58(d,J=7.0Hz,2H), 3.45(s,2H),2.85(t,J=7.0Hz,1H), MS(ESI)m / z:274.1(M+).

Embodiment 3

[0127] Example 3 Preparation of 2-mercapto-N-(4-(methyl(phenyl)amino)phenyl)acetamide (3)

[0128] 3 was prepared according to the general method.

[0129] 1 H NMR (600MHz, Chloroform-d) δ: 9.88(s,1H), 7.76–7.70(m,2H), 7.28–7.20(m,2H), 7.12–7.04(m,3H), 6.72–6.66(m , 2H), 3.62 (d, J=6.9Hz, 2H), 3.37(s, 2H), 2.85(t, J=6.9Hz, 1H), MS (ESI) m / z: 273.1 (M+).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a histone deacetylase subtype inhibitor thioacetyl arylamine compound and its use. Pharmacological experiments show that the compound of the invention has selective inhibitory effect on HDAC6 enzyme and shows high resistance to various tumor cells. Proliferative activity, low toxicity to normal cells, low potential cardiotoxicity. Moreover, it has a protective effect on nerve cells, has ideal pharmacokinetic characteristics, and has high blood-brain barrier penetration properties. The compound of the present invention has further development prospects as an anti-tumor or neurodegenerative disease therapeutic agent with high efficiency and low toxicity. The general structural formula of the histone deacetylase subtype inhibitor thioacetylarylamine compound is as follows:

Description

technical field [0001] The invention relates to a class of histone deacetylase subtype inhibitors containing sulfur structures and their application in treating tumors or neurodegenerative diseases. Background technique [0002] Histone deacetylases (histone deacetylases, HDACs) can catalyze the deacetylation process of histone and non-histone proteins, and histone acetyltransferases (histone acetyltransferases, HATs) jointly regulate the level of acetylation in cells, thereby regulating gene expression. Express. Currently, there are 18 known subtypes of mammalian HDACs, which are divided into four classes: class I (HDAC1, HDAC2, HDAC3, HDAC8); class II is further divided into IIa (HDAC4, HDAC5, HDAC7, HDAC9) and IIb (HDAC6, HDAC10) two subfamilies; class III (Sirt1-Sirt7); class IV (HDAC11). [0003] Currently there are 5 histone deacetylase inhibitors (HDACi) on the market, namely vorinostat, belinostat, panobinostat, romidepsin ( romidepsin) and chidamide (chidamide), ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/48C07D239/42C07D213/75C07D213/76C07D413/12C07D401/12C07D239/94C07C323/52A61P35/00A61P25/00
CPCC07D239/48C07D239/42C07D213/75C07D213/76C07D413/12C07D401/12C07D239/94C07C323/52A61P35/00A61P25/00
Inventor 李建其郭政张庆伟王冠浦强张子学
Owner SHANGHAI ZHONGZE THERAPEUTICS CO LTD